date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.518082409857771.
The log-likelihood improved by 2.945.
Iteration 2 of at most 500:
Optimizing with step length 0.554811508250447.
The log-likelihood improved by 3.137.
Iteration 3 of at most 500:
Optimizing with step length 0.917655120944053.
The log-likelihood improved by 3.825.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.099.
Step length converged once. Increasing MCMC sample size.
Iteration 5 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.762.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       5       17     1178     1097      777      316      364      344 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     319      235      159       77       50       28       14        9 
degree16 degree17 degree19 
       4        5        2 
1 
disease_progression 
H-positive risk:  837 877 112 842 443 130 918 437 129 69 135 71 
H-negative risk:  877 837 918 842 437 443 130 112 135 129 71 69 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
69 new agents 
2 
disease_progression 
H-positive risk:  839 882 112 850 439 130 906 436 130 69 136 71 
H-negative risk:  882 839 906 850 436 439 130 112 136 130 71 69 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
3 
disease_progression 
H-positive risk:  845 883 114 845 439 132 907 431 132 69 134 69 
H-negative risk:  883 845 907 845 431 439 132 114 134 132 69 69 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 4 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
4 
disease_progression 
H-positive risk:  849 892 118 840 430 134 907 427 132 68 134 69 
H-negative risk:  892 849 907 840 427 430 134 118 134 132 69 68 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 4 5 

clinical_engagement 
diagnosis 
demography 
52 new agents 
5 
disease_progression 
H-positive risk:  852 897 122 834 431 134 904 428 131 64 134 69 
H-negative risk:  897 852 904 834 428 431 134 122 134 131 69 64 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 8 5 

clinical_engagement 
diagnosis 
demography 
44 new agents 
6 
disease_progression 
H-positive risk:  854 898 122 829 433 136 908 424 129 64 135 68 
H-negative risk:  898 854 908 829 424 433 136 122 135 129 68 64 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 11 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  857 900 124 828 425 137 908 421 129 65 139 67 
H-negative risk:  900 857 908 828 421 425 137 124 139 129 67 65 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 15 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
8 
disease_progression 
H-positive risk:  861 900 122 831 422 138 907 420 128 65 140 66 
H-negative risk:  900 861 907 831 420 422 138 122 140 128 66 65 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 17 6 

clinical_engagement 
diagnosis 
demography 
50 new agents 
9 
disease_progression 
H-positive risk:  867 906 123 830 416 137 911 412 125 67 141 65 
H-negative risk:  906 867 911 830 412 416 137 123 141 125 65 67 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 18 6 

clinical_engagement 
diagnosis 
demography 
54 new agents 
10 
disease_progression 
H-positive risk:  874 911 124 825 412 140 903 416 125 67 138 65 
H-negative risk:  911 874 903 825 416 412 140 124 138 125 65 67 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 19 6 

clinical_engagement 
diagnosis 
demography 
73 new agents 
11 
disease_progression 
H-positive risk:  876 922 124 817 407 141 901 411 127 70 138 66 
H-negative risk:  922 876 901 817 411 407 141 124 138 127 66 70 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 20 6 

clinical_engagement 
diagnosis 
demography 
61 new agents 
12 
disease_progression 
H-positive risk:  885 926 123 810 411 140 899 405 128 69 138 66 
H-negative risk:  926 885 899 810 405 411 140 123 138 128 66 69 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 22 7 

clinical_engagement 
diagnosis 
demography 
54 new agents 
13 
disease_progression 
H-positive risk:  821 852 112 885 405 129 964 409 139 67 149 68 
H-negative risk:  852 821 964 885 409 405 129 112 149 139 68 67 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 25 7 

clinical_engagement 
diagnosis 
demography 
206 new agents 
14 
disease_progression 
H-positive risk:  846 882 115 841 425 131 917 431 133 59 148 72 
H-negative risk:  882 846 917 841 431 425 131 115 148 133 72 59 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 27 7 

clinical_engagement 
diagnosis 
demography 
68 new agents 
15 
disease_progression 
H-positive risk:  851 880 115 842 418 132 914 432 133 58 153 72 
H-negative risk:  880 851 914 842 432 418 132 115 153 133 72 58 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
54 new agents 
16 
disease_progression 
H-positive risk:  858 881 113 844 419 131 909 433 132 57 152 71 
H-negative risk:  881 858 909 844 433 419 131 113 152 132 71 57 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 28 7 

clinical_engagement 
diagnosis 
demography 
63 new agents 
17 
disease_progression 
H-positive risk:  868 887 111 838 410 130 909 431 135 57 152 72 
H-negative risk:  887 868 909 838 431 410 130 111 152 135 72 57 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 29 6 

clinical_engagement 
diagnosis 
demography 
61 new agents 
18 
disease_progression 
H-positive risk:  868 895 112 842 405 133 903 428 134 58 150 72 
H-negative risk:  895 868 903 842 428 405 133 112 150 134 72 58 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 33 6 

clinical_engagement 
diagnosis 
demography 
61 new agents 
19 
disease_progression 
H-positive risk:  877 890 110 853 399 131 900 424 133 59 150 74 
H-negative risk:  890 877 900 853 424 399 131 110 150 133 74 59 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 35 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
20 
disease_progression 
H-positive risk:  877 889 112 857 398 132 906 416 132 59 150 72 
H-negative risk:  889 877 906 857 416 398 132 112 150 132 72 59 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 38 7 

clinical_engagement 
diagnosis 
demography 
68 new agents 
21 
disease_progression 
H-positive risk:  882 890 114 859 397 133 904 408 131 60 150 72 
H-negative risk:  890 882 904 859 408 397 133 114 150 131 72 60 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
42 new agents 
22 
disease_progression 
H-positive risk:  885 894 115 856 395 134 902 406 133 58 152 70 
H-negative risk:  894 885 902 856 406 395 134 115 152 133 70 58 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
23 
disease_progression 
H-positive risk:  894 894 112 855 392 136 901 405 132 56 153 70 
H-negative risk:  894 894 901 855 405 392 136 112 153 132 70 56 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 41 10 

clinical_engagement 
diagnosis 
demography 
62 new agents 
24 
disease_progression 
H-positive risk:  900 893 112 851 394 136 903 402 129 56 154 70 
H-negative risk:  893 900 903 851 402 394 136 112 154 129 70 56 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 41 12 

clinical_engagement 
diagnosis 
demography 
59 new agents 
25 
disease_progression 
H-positive risk:  829 818 105 924 390 125 977 399 143 54 166 70 
H-negative risk:  818 829 977 924 399 390 125 105 166 143 70 54 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 43 10 

clinical_engagement 
diagnosis 
demography 
196 new agents 
26 
disease_progression 
H-positive risk:  850 853 107 893 399 130 949 410 132 54 153 70 
H-negative risk:  853 850 949 893 410 399 130 107 153 132 70 54 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 43 9 

clinical_engagement 
diagnosis 
demography 
70 new agents 
27 
disease_progression 
H-positive risk:  854 859 110 883 402 133 950 403 129 53 153 71 
H-negative risk:  859 854 950 883 403 402 133 110 153 129 71 53 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 45 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
28 
disease_progression 
H-positive risk:  856 866 111 883 395 133 951 399 128 53 155 70 
H-negative risk:  866 856 951 883 399 395 133 111 155 128 70 53 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 47 10 

clinical_engagement 
diagnosis 
demography 
64 new agents 
29 
disease_progression 
H-positive risk:  861 864 112 883 389 133 954 400 127 53 153 71 
H-negative risk:  864 861 954 883 400 389 133 112 153 127 71 53 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 50 11 

clinical_engagement 
diagnosis 
demography 
54 new agents 
30 
disease_progression 
H-positive risk:  871 869 112 883 383 129 953 400 127 51 153 69 
H-negative risk:  869 871 953 883 400 383 129 112 153 127 69 51 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 49 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
31 
disease_progression 
H-positive risk:  871 871 113 886 375 126 952 406 126 51 153 70 
H-negative risk:  871 871 952 886 406 375 126 113 153 126 70 51 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 48 14 

clinical_engagement 
diagnosis 
demography 
51 new agents 
32 
disease_progression 
H-positive risk:  876 873 113 889 369 127 949 406 129 50 151 68 
H-negative risk:  873 876 949 889 406 369 127 113 151 129 68 50 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 48 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
33 
disease_progression 
H-positive risk:  876 876 116 888 368 128 944 406 127 50 153 68 
H-negative risk:  876 876 944 888 406 368 128 116 153 127 68 50 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 51 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
34 
disease_progression 
H-positive risk:  885 876 117 891 365 130 932 404 128 49 154 69 
H-negative risk:  876 885 932 891 404 365 130 117 154 128 69 49 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 52 13 

clinical_engagement 
diagnosis 
demography 
63 new agents 
35 
disease_progression 
H-positive risk:  896 879 117 886 364 127 927 408 127 49 153 67 
H-negative risk:  879 896 927 886 408 364 127 117 153 127 67 49 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 53 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
36 
disease_progression 
H-positive risk:  894 883 118 886 367 128 922 407 126 48 155 66 
H-negative risk:  883 894 922 886 407 367 128 118 155 126 66 48 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 53 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
37 
disease_progression 
H-positive risk:  830 821 110 948 369 119 985 407 138 47 160 66 
H-negative risk:  821 830 985 948 407 369 119 110 160 138 66 47 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
159 new agents 
38 
disease_progression 
H-positive risk:  839 843 111 926 389 119 947 424 134 48 154 66 
H-negative risk:  843 839 947 926 424 389 119 111 154 134 66 48 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 58 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
39 
disease_progression 
H-positive risk:  843 840 112 926 391 121 950 425 127 47 152 66 
H-negative risk:  840 843 950 926 425 391 121 112 152 127 66 47 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 61 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
40 
disease_progression 
H-positive risk:  848 848 112 921 396 120 944 424 126 47 149 65 
H-negative risk:  848 848 944 921 424 396 120 112 149 126 65 47 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 64 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
41 
disease_progression 
H-positive risk:  843 850 113 922 393 119 944 426 129 46 149 66 
H-negative risk:  850 843 944 922 426 393 119 113 149 129 66 46 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
42 
disease_progression 
H-positive risk:  849 849 114 933 387 120 940 419 129 48 146 66 
H-negative risk:  849 849 940 933 419 387 120 114 146 129 66 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
43 
disease_progression 
H-positive risk:  857 847 115 926 387 122 939 415 130 47 148 67 
H-negative risk:  847 857 939 926 415 387 122 115 148 130 67 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 68 17 

clinical_engagement 
diagnosis 
demography 
54 new agents 
44 
disease_progression 
H-positive risk:  853 858 115 927 385 122 942 412 129 45 145 67 
H-negative risk:  858 853 942 927 412 385 122 115 145 129 67 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 67 17 

clinical_engagement 
diagnosis 
demography 
58 new agents 
45 
disease_progression 
H-positive risk:  855 866 117 922 384 125 940 405 130 45 146 65 
H-negative risk:  866 855 940 922 405 384 125 117 146 130 65 45 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
46 
disease_progression 
H-positive risk:  853 868 119 920 382 126 942 404 130 44 145 67 
H-negative risk:  868 853 942 920 404 382 126 119 145 130 67 44 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
47 
disease_progression 
H-positive risk:  853 871 122 916 380 127 943 406 129 45 142 66 
H-negative risk:  871 853 943 916 406 380 127 122 142 129 66 45 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  854 871 122 923 376 126 944 402 130 45 139 68 
H-negative risk:  871 854 944 923 402 376 126 122 139 130 68 45 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
49 
disease_progression 
H-positive risk:  792 837 112 960 381 122 1009 394 134 45 149 65 
H-negative risk:  837 792 1009 960 394 381 122 112 149 134 65 45 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
147 new agents 
50 
disease_progression 
H-positive risk:  806 848 114 956 382 125 964 416 129 52 146 62 
H-negative risk:  848 806 964 956 416 382 125 114 146 129 62 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
51 
disease_progression 
H-positive risk:  821 851 114 955 376 125 945 422 134 53 143 61 
H-negative risk:  851 821 945 955 422 376 125 114 143 134 61 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
52 
disease_progression 
H-positive risk:  824 857 115 950 373 125 947 419 132 54 143 61 
H-negative risk:  857 824 947 950 419 373 125 115 143 132 61 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
53 
disease_progression 
H-positive risk:  828 856 115 950 365 123 952 414 135 56 148 58 
H-negative risk:  856 828 952 950 414 365 123 115 148 135 58 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
54 
disease_progression 
H-positive risk:  824 852 114 961 365 124 960 407 131 56 147 59 
H-negative risk:  852 824 960 961 407 365 124 114 147 131 59 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
55 
disease_progression 
H-positive risk:  832 857 113 963 358 123 955 408 133 53 146 59 
H-negative risk:  857 832 955 963 408 358 123 113 146 133 59 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
56 
disease_progression 
H-positive risk:  828 862 110 960 355 128 968 405 131 52 141 60 
H-negative risk:  862 828 968 960 405 355 128 110 141 131 60 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
57 
disease_progression 
H-positive risk:  830 870 111 959 357 128 964 397 130 52 141 61 
H-negative risk:  870 830 964 959 397 357 128 111 141 130 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
58 
disease_progression 
H-positive risk:  831 875 112 954 359 127 965 395 128 53 140 61 
H-negative risk:  875 831 965 954 395 359 127 112 140 128 61 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
59 
disease_progression 
H-positive risk:  831 880 113 960 355 126 968 393 128 47 139 60 
H-negative risk:  880 831 968 960 393 355 126 113 139 128 60 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
60 
disease_progression 
H-positive risk:  830 885 112 967 346 125 966 390 130 48 140 61 
H-negative risk:  885 830 966 967 390 346 125 112 140 130 61 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
61 
disease_progression 
H-positive risk:  783 830 103 1019 349 115 1017 389 136 48 152 59 
H-negative risk:  830 783 1017 1019 389 349 115 103 152 136 59 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
119 new agents 
62 
disease_progression 
H-positive risk:  783 836 107 1005 362 115 1007 397 132 49 150 57 
H-negative risk:  836 783 1007 1005 397 362 115 107 150 132 57 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
63 
disease_progression 
H-positive risk:  783 835 109 993 374 112 1005 401 133 49 147 59 
H-negative risk:  835 783 1005 993 401 374 112 109 147 133 59 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
64 
disease_progression 
H-positive risk:  784 841 112 989 374 111 1010 394 134 51 143 57 
H-negative risk:  841 784 1010 989 394 374 111 112 143 134 57 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
65 
disease_progression 
H-positive risk:  781 843 113 991 376 112 1012 391 133 49 143 56 
H-negative risk:  843 781 1012 991 391 376 112 113 143 133 56 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
66 
disease_progression 
H-positive risk:  786 847 108 993 378 114 1011 383 132 47 142 59 
H-negative risk:  847 786 1011 993 383 378 114 108 142 132 59 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
67 
disease_progression 
H-positive risk:  777 851 105 1000 376 116 1007 386 130 48 145 59 
H-negative risk:  851 777 1007 1000 386 376 116 105 145 130 59 48 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
50 new agents 
68 
disease_progression 
H-positive risk:  783 850 104 1002 374 114 1000 385 133 49 145 61 
H-negative risk:  850 783 1000 1002 385 374 114 104 145 133 61 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
69 
disease_progression 
H-positive risk:  783 844 101 1004 383 114 1002 378 135 46 149 61 
H-negative risk:  844 783 1002 1004 378 383 114 101 149 135 61 46 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
52 new agents 
70 
disease_progression 
H-positive risk:  780 841 102 1006 391 113 1000 379 132 48 146 62 
H-negative risk:  841 780 1000 1006 379 391 113 102 146 132 62 48 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
71 
disease_progression 
H-positive risk:  781 836 102 1007 390 114 1013 372 132 44 147 62 
H-negative risk:  836 781 1013 1007 372 390 114 102 147 132 62 44 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
61 new agents 
72 
disease_progression 
H-positive risk:  789 833 101 997 398 114 1010 370 134 44 146 64 
H-negative risk:  833 789 1010 997 370 398 114 101 146 134 64 44 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
73 
disease_progression 
H-positive risk:  741 780 100 1050 399 111 1056 364 139 47 151 62 
H-negative risk:  780 741 1056 1050 364 399 111 100 151 139 62 47 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 96 24 

clinical_engagement 
diagnosis 
demography 
111 new agents 
74 
disease_progression 
H-positive risk:  750 787 102 1034 406 110 1047 368 135 50 149 62 
H-negative risk:  787 750 1047 1034 368 406 110 102 149 135 62 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
75 
disease_progression 
H-positive risk:  752 792 103 1036 402 105 1043 371 135 49 151 61 
H-negative risk:  792 752 1043 1036 371 402 105 103 151 135 61 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
76 
disease_progression 
H-positive risk:  757 793 102 1034 401 104 1042 373 134 51 147 62 
H-negative risk:  793 757 1042 1034 373 401 104 102 147 134 62 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
77 
disease_progression 
H-positive risk:  758 796 105 1035 401 105 1047 365 131 52 144 61 
H-negative risk:  796 758 1047 1035 365 401 105 105 144 131 61 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  761 799 105 1034 401 108 1045 360 130 53 142 62 
H-negative risk:  799 761 1045 1034 360 401 108 105 142 130 62 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
79 
disease_progression 
H-positive risk:  750 799 105 1033 403 112 1052 359 130 53 141 63 
H-negative risk:  799 750 1052 1033 359 403 112 105 141 130 63 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
80 
disease_progression 
H-positive risk:  754 805 106 1026 402 114 1051 357 129 55 140 61 
H-negative risk:  805 754 1051 1026 357 402 114 106 140 129 61 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
81 
disease_progression 
H-positive risk:  759 799 107 1028 407 113 1049 358 126 53 140 61 
H-negative risk:  799 759 1049 1028 358 407 113 107 140 126 61 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
57 new agents 
82 
disease_progression 
H-positive risk:  765 803 107 1025 398 112 1050 361 125 54 139 61 
H-negative risk:  803 765 1050 1025 361 398 112 107 139 125 61 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
83 
disease_progression 
H-positive risk:  763 803 109 1034 395 111 1055 355 125 54 136 60 
H-negative risk:  803 763 1055 1034 355 395 111 109 136 125 60 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
84 
disease_progression 
H-positive risk:  773 797 108 1036 393 113 1052 356 127 53 134 58 
H-negative risk:  797 773 1052 1036 356 393 113 108 134 127 58 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
85 
disease_progression 
H-positive risk:  740 755 108 1080 388 105 1088 363 133 50 133 57 
H-negative risk:  755 740 1088 1080 363 388 105 108 133 133 57 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
113 new agents 
86 
disease_progression 
H-positive risk:  739 767 105 1062 410 104 1054 386 130 53 131 59 
H-negative risk:  767 739 1054 1062 386 410 104 105 131 130 59 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
87 
disease_progression 
H-positive risk:  741 771 105 1055 414 106 1051 384 129 56 127 61 
H-negative risk:  771 741 1051 1055 384 414 106 105 127 129 61 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
88 
disease_progression 
H-positive risk:  751 772 107 1056 406 108 1046 380 129 57 127 61 
H-negative risk:  772 751 1046 1056 380 406 108 107 127 129 61 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
89 
disease_progression 
H-positive risk:  749 780 107 1051 410 108 1049 375 128 56 126 61 
H-negative risk:  780 749 1049 1051 375 410 108 107 126 128 61 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
90 
disease_progression 
H-positive risk:  747 782 109 1049 416 107 1052 371 128 57 125 57 
H-negative risk:  782 747 1052 1049 371 416 107 109 125 128 57 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
91 
disease_progression 
H-positive risk:  744 785 110 1043 411 109 1057 375 128 58 124 56 
H-negative risk:  785 744 1057 1043 375 411 109 110 124 128 56 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
92 
disease_progression 
H-positive risk:  745 779 112 1052 407 111 1053 372 127 60 126 56 
H-negative risk:  779 745 1053 1052 372 407 111 112 126 127 56 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
93 
disease_progression 
H-positive risk:  749 784 112 1049 403 109 1054 372 126 60 126 56 
H-negative risk:  784 749 1054 1049 372 403 109 112 126 126 56 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 89 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
94 
disease_progression 
H-positive risk:  754 783 112 1050 397 112 1049 374 128 59 124 58 
H-negative risk:  783 754 1049 1050 374 397 112 112 124 128 58 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
95 
disease_progression 
H-positive risk:  758 776 114 1048 399 113 1051 372 128 55 129 57 
H-negative risk:  776 758 1051 1048 372 399 113 114 129 128 57 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
59 new agents 
96 
disease_progression 
H-positive risk:  762 768 117 1050 399 114 1055 368 127 56 129 55 
H-negative risk:  768 762 1055 1050 368 399 114 117 129 127 55 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
97 
disease_progression 
H-positive risk:  716 715 104 1100 400 107 1107 361 133 56 146 55 
H-negative risk:  715 716 1107 1100 361 400 107 104 146 133 55 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
98 new agents 
98 
disease_progression 
H-positive risk:  714 707 106 1107 407 110 1094 374 126 59 144 52 
H-negative risk:  707 714 1094 1107 374 407 110 106 144 126 52 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
80 new agents 
99 
disease_progression 
H-positive risk:  717 713 109 1100 407 109 1084 376 130 59 139 57 
H-negative risk:  713 717 1084 1100 376 407 109 109 139 130 57 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
100 
disease_progression 
H-positive risk:  722 708 108 1097 403 110 1082 379 128 61 143 59 
H-negative risk:  708 722 1082 1097 379 403 110 108 143 128 59 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
101 
disease_progression 
H-positive risk:  721 708 106 1099 400 111 1083 376 129 63 145 59 
H-negative risk:  708 721 1083 1099 376 400 111 106 145 129 59 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
102 
disease_progression 
H-positive risk:  727 707 107 1097 400 110 1084 372 131 61 144 60 
H-negative risk:  707 727 1084 1097 372 400 110 107 144 131 60 61 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
103 
disease_progression 
H-positive risk:  727 708 106 1089 401 111 1085 378 129 60 146 60 
H-negative risk:  708 727 1085 1089 378 401 111 106 146 129 60 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
104 
disease_progression 
H-positive risk:  735 711 107 1094 393 116 1084 369 131 59 139 62 
H-negative risk:  711 735 1084 1094 369 393 116 107 139 131 62 59 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
105 
disease_progression 
H-positive risk:  728 713 106 1097 395 116 1086 370 129 59 139 62 
H-negative risk:  713 728 1086 1097 370 395 116 106 139 129 62 59 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
106 
disease_progression 
H-positive risk:  727 710 105 1103 391 117 1086 369 131 59 140 62 
H-negative risk:  710 727 1086 1103 369 391 117 105 140 131 62 59 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
107 
disease_progression 
H-positive risk:  732 716 107 1101 388 119 1080 367 132 58 138 62 
H-negative risk:  716 732 1080 1101 367 388 119 107 138 132 62 58 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
108 
disease_progression 
H-positive risk:  730 713 107 1108 379 120 1092 366 130 56 141 58 
H-negative risk:  713 730 1092 1108 366 379 120 107 141 130 58 56 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
109 
disease_progression 
H-positive risk:  689 673 101 1147 378 114 1132 368 139 57 145 57 
H-negative risk:  673 689 1132 1147 368 378 114 101 145 139 57 57 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
99 new agents 
110 
disease_progression 
H-positive risk:  675 669 100 1147 393 116 1131 373 136 58 145 57 
H-negative risk:  669 675 1131 1147 373 393 116 100 145 136 57 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
94 new agents 
111 
disease_progression 
H-positive risk:  676 681 101 1131 394 116 1132 373 137 57 146 56 
H-negative risk:  681 676 1132 1131 373 394 116 101 146 137 56 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
112 
disease_progression 
H-positive risk:  678 675 100 1138 396 115 1127 370 140 57 150 54 
H-negative risk:  675 678 1127 1138 370 396 115 100 150 140 54 57 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
113 
disease_progression 
H-positive risk:  681 671 100 1128 399 117 1130 367 142 58 152 55 
H-negative risk:  671 681 1130 1128 367 399 117 100 152 142 55 58 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 69 14 

clinical_engagement 
diagnosis 
demography 
68 new agents 
114 
disease_progression 
H-positive risk:  675 678 100 1123 406 118 1125 367 142 58 151 57 
H-negative risk:  678 675 1125 1123 367 406 118 100 151 142 57 58 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 68 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
115 
disease_progression 
H-positive risk:  679 688 102 1130 394 116 1117 369 143 58 147 57 
H-negative risk:  688 679 1117 1130 369 394 116 102 147 143 57 58 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
51 new agents 
116 
disease_progression 
H-positive risk:  671 687 103 1131 398 117 1120 372 142 57 143 59 
H-negative risk:  687 671 1120 1131 372 398 117 103 143 142 59 57 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
117 
disease_progression 
H-positive risk:  679 691 100 1137 390 115 1119 368 141 55 148 57 
H-negative risk:  691 679 1119 1137 368 390 115 100 148 141 57 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
118 
disease_progression 
H-positive risk:  679 688 100 1135 389 115 1127 372 142 51 146 56 
H-negative risk:  688 679 1127 1135 372 389 115 100 146 142 56 51 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
119 
disease_progression 
H-positive risk:  674 690 99 1133 392 114 1128 370 146 50 148 56 
H-negative risk:  690 674 1128 1133 370 392 114 99 148 146 56 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
77 new agents 
120 
disease_progression 
H-positive risk:  673 685 98 1136 393 114 1131 368 145 49 151 57 
H-negative risk:  685 673 1131 1136 368 393 114 98 151 145 57 49 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 71 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
121 
disease_progression 
H-positive risk:  637 645 92 1185 398 103 1156 367 157 49 153 58 
H-negative risk:  645 637 1156 1185 367 398 103 92 153 157 58 49 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
95 new agents 
122 
disease_progression 
H-positive risk:  632 638 91 1188 404 102 1145 382 161 45 152 60 
H-negative risk:  638 632 1145 1188 382 404 102 91 152 161 60 45 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
123 
disease_progression 
H-positive risk:  637 638 91 1181 408 101 1141 390 162 45 146 60 
H-negative risk:  638 637 1141 1181 390 408 101 91 146 162 60 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  629 646 91 1174 408 97 1150 386 161 49 150 59 
H-negative risk:  646 629 1150 1174 386 408 97 91 150 161 59 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
125 
disease_progression 
H-positive risk:  635 651 94 1176 401 97 1143 387 162 46 148 60 
H-negative risk:  651 635 1143 1176 387 401 97 94 148 162 60 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
126 
disease_progression 
H-positive risk:  632 650 94 1176 398 96 1149 384 165 47 152 57 
H-negative risk:  650 632 1149 1176 384 398 96 94 152 165 57 47 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
127 
disease_progression 
H-positive risk:  635 647 98 1175 401 94 1145 388 165 45 152 55 
H-negative risk:  647 635 1145 1175 388 401 94 98 152 165 55 45 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
128 
disease_progression 
H-positive risk:  639 640 96 1178 405 90 1142 389 168 44 153 56 
H-negative risk:  640 639 1142 1178 389 405 90 96 153 168 56 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
129 
disease_progression 
H-positive risk:  633 640 97 1185 409 95 1136 389 169 42 149 56 
H-negative risk:  640 633 1136 1185 389 409 95 97 149 169 56 42 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
130 
disease_progression 
H-positive risk:  635 641 98 1186 405 94 1141 387 171 43 145 54 
H-negative risk:  641 635 1141 1186 387 405 94 98 145 171 54 43 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
131 
disease_progression 
H-positive risk:  640 648 97 1178 406 95 1140 385 172 41 145 53 
H-negative risk:  648 640 1140 1178 385 406 95 97 145 172 53 41 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
132 
disease_progression 
H-positive risk:  644 650 95 1172 407 93 1140 389 170 42 142 56 
H-negative risk:  650 644 1140 1172 389 407 93 95 142 170 56 42 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 63 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
133 
disease_progression 
H-positive risk:  648 660 90 1173 399 94 1137 386 170 44 144 55 
H-negative risk:  660 648 1137 1173 386 399 94 90 144 170 55 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
105 new agents 
134 
disease_progression 
H-positive risk:  654 648 89 1187 391 93 1133 396 166 45 146 52 
H-negative risk:  648 654 1133 1187 396 391 93 89 146 166 52 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 63 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
135 
disease_progression 
H-positive risk:  660 651 89 1174 394 95 1125 405 160 47 147 53 
H-negative risk:  651 660 1125 1174 405 394 95 89 147 160 53 47 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 61 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
136 
disease_progression 
H-positive risk:  668 648 90 1178 382 98 1129 404 160 45 145 53 
H-negative risk:  648 668 1129 1178 404 382 98 90 145 160 53 45 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 61 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
137 
disease_progression 
H-positive risk:  668 650 92 1170 391 98 1137 392 159 46 144 53 
H-negative risk:  650 668 1137 1170 392 391 98 92 144 159 53 46 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
138 
disease_progression 
H-positive risk:  675 646 93 1175 392 101 1132 386 160 45 144 51 
H-negative risk:  646 675 1132 1175 386 392 101 93 144 160 51 45 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
139 
disease_progression 
H-positive risk:  670 655 92 1166 391 105 1140 385 157 47 143 49 
H-negative risk:  655 670 1140 1166 385 391 105 92 143 157 49 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
140 
disease_progression 
H-positive risk:  670 658 92 1157 388 104 1150 383 160 47 144 47 
H-negative risk:  658 670 1150 1157 383 388 104 92 144 160 47 47 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
141 
disease_progression 
H-positive risk:  664 662 93 1153 389 105 1154 387 159 47 138 49 
H-negative risk:  662 664 1154 1153 387 389 105 93 138 159 49 47 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
142 
disease_progression 
H-positive risk:  664 663 93 1157 391 106 1153 384 160 45 135 49 
H-negative risk:  663 664 1153 1157 384 391 106 93 135 160 49 45 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
143 
disease_progression 
H-positive risk:  665 668 92 1158 386 107 1156 379 163 43 136 47 
H-negative risk:  668 665 1156 1158 379 386 107 92 136 163 47 43 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
144 
disease_progression 
H-positive risk:  658 675 95 1152 384 105 1158 382 167 43 136 45 
H-negative risk:  675 658 1158 1152 382 384 105 95 136 167 45 43 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
145 
disease_progression 
H-positive risk:  658 678 97 1153 384 103 1161 377 168 42 137 42 
H-negative risk:  678 658 1161 1153 377 384 103 97 137 168 42 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
146 
disease_progression 
H-positive risk:  662 670 97 1150 395 102 1156 380 163 47 133 45 
H-negative risk:  670 662 1156 1150 380 395 102 97 133 163 45 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
147 
disease_progression 
H-positive risk:  662 672 96 1145 399 103 1142 390 161 49 136 45 
H-negative risk:  672 662 1142 1145 390 399 103 96 136 161 45 49 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
148 
disease_progression 
H-positive risk:  667 671 94 1148 399 100 1139 387 160 49 139 47 
H-negative risk:  671 667 1139 1148 387 399 100 94 139 160 47 49 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
149 
disease_progression 
H-positive risk:  670 675 95 1149 393 99 1142 385 160 48 138 46 
H-negative risk:  675 670 1142 1149 385 393 99 95 138 160 46 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
150 
disease_progression 
H-positive risk:  668 671 94 1145 391 98 1147 393 163 47 139 44 
H-negative risk:  671 668 1147 1145 393 391 98 94 139 163 44 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
151 
disease_progression 
H-positive risk:  675 664 96 1148 380 98 1146 397 163 49 140 44 
H-negative risk:  664 675 1146 1148 397 380 98 96 140 163 44 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
152 
disease_progression 
H-positive risk:  676 670 98 1145 373 98 1139 400 168 47 143 43 
H-negative risk:  670 676 1139 1145 400 373 98 98 143 168 43 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
153 
disease_progression 
H-positive risk:  675 674 96 1155 362 100 1132 406 168 45 143 44 
H-negative risk:  674 675 1132 1155 406 362 100 96 143 168 44 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
154 
disease_progression 
H-positive risk:  673 675 96 1160 359 102 1133 406 168 47 138 43 
H-negative risk:  675 673 1133 1160 406 359 102 96 138 168 43 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
155 
disease_progression 
H-positive risk:  663 670 93 1168 362 102 1137 409 170 48 135 43 
H-negative risk:  670 663 1137 1168 409 362 102 93 135 170 43 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
94 new agents 
156 
disease_progression 
H-positive risk:  663 674 92 1169 358 101 1136 414 164 47 136 46 
H-negative risk:  674 663 1136 1169 414 358 101 92 136 164 46 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  664 669 92 1171 357 103 1135 411 168 47 137 46 
H-negative risk:  669 664 1135 1171 411 357 103 92 137 168 46 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
100 new agents 
158 
disease_progression 
H-positive risk:  666 670 93 1171 362 103 1121 415 164 51 136 48 
H-negative risk:  670 666 1121 1171 415 362 103 93 136 164 48 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
91 new agents 
159 
disease_progression 
H-positive risk:  664 667 91 1171 364 100 1129 408 165 55 140 46 
H-negative risk:  667 664 1129 1171 408 364 100 91 140 165 46 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
160 
disease_progression 
H-positive risk:  646 674 90 1174 365 101 1132 406 167 54 145 46 
H-negative risk:  674 646 1132 1174 406 365 101 90 145 167 46 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
161 
disease_progression 
H-positive risk:  646 667 90 1175 364 101 1140 408 164 55 144 46 
H-negative risk:  667 646 1140 1175 408 364 101 90 144 164 46 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
162 
disease_progression 
H-positive risk:  650 664 88 1185 362 104 1130 404 170 54 142 47 
H-negative risk:  664 650 1130 1185 404 362 104 88 142 170 47 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
163 
disease_progression 
H-positive risk:  645 656 87 1188 367 105 1134 408 172 54 138 46 
H-negative risk:  656 645 1134 1188 408 367 105 87 138 172 46 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
164 
disease_progression 
H-positive risk:  656 644 84 1189 368 106 1123 412 176 53 144 45 
H-negative risk:  644 656 1123 1189 412 368 106 84 144 176 45 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  653 651 84 1181 367 104 1125 413 178 53 146 45 
H-negative risk:  651 653 1125 1181 413 367 104 84 146 178 45 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
166 
disease_progression 
H-positive risk:  651 657 85 1175 369 104 1129 412 175 51 145 47 
H-negative risk:  657 651 1129 1175 412 369 104 85 145 175 47 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 95 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
167 
disease_progression 
H-positive risk:  662 654 86 1179 364 101 1126 409 175 53 148 43 
H-negative risk:  654 662 1126 1179 409 364 101 86 148 175 43 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
168 
disease_progression 
H-positive risk:  660 654 84 1175 370 100 1129 409 173 53 148 45 
H-negative risk:  654 660 1129 1175 409 370 100 84 148 173 45 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
169 
disease_progression 
H-positive risk:  657 651 86 1178 378 100 1120 411 172 53 149 45 
H-negative risk:  651 657 1120 1178 411 378 100 86 149 172 45 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
96 new agents 
170 
disease_progression 
H-positive risk:  663 649 86 1175 374 100 1115 420 172 50 147 49 
H-negative risk:  649 663 1115 1175 420 374 100 86 147 172 49 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
171 
disease_progression 
H-positive risk:  654 649 85 1176 377 98 1127 413 171 51 153 46 
H-negative risk:  649 654 1127 1176 413 377 98 85 153 171 46 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  657 643 88 1168 381 99 1120 417 176 53 150 48 
H-negative risk:  643 657 1120 1168 417 381 99 88 150 176 48 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
173 
disease_progression 
H-positive risk:  656 637 87 1172 378 99 1122 421 175 56 149 48 
H-negative risk:  637 656 1122 1172 421 378 99 87 149 175 48 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
174 
disease_progression 
H-positive risk:  656 638 89 1170 381 99 1123 415 173 58 149 49 
H-negative risk:  638 656 1123 1170 415 381 99 89 149 173 49 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
175 
disease_progression 
H-positive risk:  643 642 88 1173 378 99 1129 416 172 58 153 49 
H-negative risk:  642 643 1129 1173 416 378 99 88 153 172 49 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 96 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
176 
disease_progression 
H-positive risk:  638 644 87 1183 377 97 1128 411 171 57 155 52 
H-negative risk:  644 638 1128 1183 411 377 97 87 155 171 52 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 99 13 

clinical_engagement 
diagnosis 
demography 
79 new agents 
177 
disease_progression 
H-positive risk:  636 646 89 1178 376 96 1137 407 171 57 156 51 
H-negative risk:  646 636 1137 1178 407 376 96 89 156 171 51 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 97 12 

clinical_engagement 
diagnosis 
demography 
76 new agents 
178 
disease_progression 
H-positive risk:  633 648 87 1174 383 96 1135 407 173 56 158 50 
H-negative risk:  648 633 1135 1174 407 383 96 87 158 173 50 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 94 12 

clinical_engagement 
diagnosis 
demography 
85 new agents 
179 
disease_progression 
H-positive risk:  634 646 88 1177 382 99 1134 399 173 58 162 48 
H-negative risk:  646 634 1134 1177 399 382 99 88 162 173 48 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 93 12 

clinical_engagement 
diagnosis 
demography 
80 new agents 
180 
disease_progression 
H-positive risk:  638 643 91 1185 381 97 1128 401 176 55 159 46 
H-negative risk:  643 638 1128 1185 401 381 97 91 159 176 46 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 92 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
181 
disease_progression 
H-positive risk:  637 648 92 1178 382 101 1117 403 179 55 158 50 
H-negative risk:  648 637 1117 1178 403 382 101 92 158 179 50 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 92 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
182 
disease_progression 
H-positive risk:  635 649 90 1167 393 98 1112 411 178 59 157 51 
H-negative risk:  649 635 1112 1167 411 393 98 90 157 178 51 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
84 new agents 
183 
disease_progression 
H-positive risk:  631 645 94 1163 401 100 1110 409 178 57 158 54 
H-negative risk:  645 631 1110 1163 409 401 100 94 158 178 54 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
77 new agents 
184 
disease_progression 
H-positive risk:  622 645 95 1169 407 98 1102 410 179 56 163 54 
H-negative risk:  645 622 1102 1169 410 407 98 95 163 179 54 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
185 
disease_progression 
H-positive risk:  612 648 97 1163 419 99 1104 407 182 54 163 52 
H-negative risk:  648 612 1104 1163 407 419 99 97 163 182 52 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
186 
disease_progression 
H-positive risk:  611 649 101 1162 423 102 1097 403 183 53 163 53 
H-negative risk:  649 611 1097 1162 403 423 102 101 163 183 53 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
187 
disease_progression 
H-positive risk:  607 652 100 1159 424 101 1095 405 181 57 165 54 
H-negative risk:  652 607 1095 1159 405 424 101 100 165 181 54 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
89 new agents 
188 
disease_progression 
H-positive risk:  606 665 100 1150 426 101 1095 403 181 54 165 54 
H-negative risk:  665 606 1095 1150 403 426 101 100 165 181 54 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 96 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
189 
disease_progression 
H-positive risk:  610 668 102 1153 426 103 1093 400 176 52 164 53 
H-negative risk:  668 610 1093 1153 400 426 103 102 164 176 53 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 95 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
190 
disease_progression 
H-positive risk:  610 667 101 1155 427 103 1087 405 174 51 164 56 
H-negative risk:  667 610 1087 1155 405 427 103 101 164 174 56 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 96 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
191 
disease_progression 
H-positive risk:  610 663 103 1160 431 102 1081 403 172 53 163 59 
H-negative risk:  663 610 1081 1160 403 431 102 103 163 172 59 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 95 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
192 
disease_progression 
H-positive risk:  610 661 105 1170 423 100 1080 406 171 53 163 58 
H-negative risk:  661 610 1080 1170 406 423 100 105 163 171 58 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
193 
disease_progression 
H-positive risk:  617 667 108 1175 420 100 1072 399 172 52 164 54 
H-negative risk:  667 617 1072 1175 399 420 100 108 164 172 54 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
194 
disease_progression 
H-positive risk:  615 669 104 1168 433 101 1063 404 173 53 164 53 
H-negative risk:  669 615 1063 1168 404 433 101 104 164 173 53 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 90 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
195 
disease_progression 
H-positive risk:  617 669 102 1175 440 103 1043 412 167 54 163 55 
H-negative risk:  669 617 1043 1175 412 440 103 102 163 167 55 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 90 13 

clinical_engagement 
diagnosis 
demography 
87 new agents 
196 
disease_progression 
H-positive risk:  623 666 102 1182 433 101 1039 409 168 56 166 55 
H-negative risk:  666 623 1039 1182 409 433 101 102 166 168 55 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 88 12 

clinical_engagement 
diagnosis 
demography 
62 new agents 
197 
disease_progression 
H-positive risk:  628 664 101 1184 433 98 1033 413 168 56 167 55 
H-negative risk:  664 628 1033 1184 413 433 98 101 167 168 55 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 86 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
198 
disease_progression 
H-positive risk:  632 660 100 1180 430 95 1035 414 171 58 170 55 
H-negative risk:  660 632 1035 1180 414 430 95 100 170 171 55 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
62 new agents 
199 
disease_progression 
H-positive risk:  635 665 101 1160 436 95 1042 412 167 60 172 55 
H-negative risk:  665 635 1042 1160 412 436 95 101 172 167 55 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
81 new agents 
200 
disease_progression 
H-positive risk:  645 665 103 1159 431 96 1042 412 163 64 167 53 
H-negative risk:  665 645 1042 1159 412 431 96 103 167 163 53 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 87 12 

clinical_engagement 
diagnosis 
demography 
87 new agents 
201 
disease_progression 
H-positive risk:  644 674 102 1158 428 95 1043 408 162 66 171 49 
H-negative risk:  674 644 1043 1158 408 428 95 102 171 162 49 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 89 12 

clinical_engagement 
diagnosis 
demography 
65 new agents 
202 
disease_progression 
H-positive risk:  640 668 102 1158 427 97 1050 406 165 63 174 50 
H-negative risk:  668 640 1050 1158 406 427 97 102 174 165 50 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 93 12 

clinical_engagement 
diagnosis 
demography 
75 new agents 
203 
disease_progression 
H-positive risk:  645 674 98 1157 423 97 1048 407 162 63 176 50 
H-negative risk:  674 645 1048 1157 407 423 97 98 176 162 50 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 93 13 

clinical_engagement 
diagnosis 
demography 
95 new agents 
204 
disease_progression 
H-positive risk:  647 684 104 1156 413 95 1044 409 163 62 174 49 
H-negative risk:  684 647 1044 1156 409 413 95 104 174 163 49 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 94 13 

clinical_engagement 
diagnosis 
demography 
83 new agents 
205 
disease_progression 
H-positive risk:  652 685 106 1152 415 94 1041 410 161 61 175 48 
H-negative risk:  685 652 1041 1152 410 415 94 106 175 161 48 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 94 11 

clinical_engagement 
diagnosis 
demography 
80 new agents 
206 
disease_progression 
H-positive risk:  650 686 106 1128 432 94 1042 418 160 63 174 47 
H-negative risk:  686 650 1042 1128 418 432 94 106 174 160 47 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 94 12 

clinical_engagement 
diagnosis 
demography 
57 new agents 
207 
disease_progression 
H-positive risk:  644 692 103 1122 437 91 1042 425 160 66 173 45 
H-negative risk:  692 644 1042 1122 425 437 91 103 173 160 45 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 96 13 

clinical_engagement 
diagnosis 
demography 
95 new agents 
208 
disease_progression 
H-positive risk:  645 693 101 1107 440 96 1053 420 159 66 174 46 
H-negative risk:  693 645 1053 1107 420 440 96 101 174 159 46 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 95 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
209 
disease_progression 
H-positive risk:  655 693 102 1112 439 93 1041 422 160 67 171 45 
H-negative risk:  693 655 1041 1112 422 439 93 102 171 160 45 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 93 13 

clinical_engagement 
diagnosis 
demography 
78 new agents 
210 
disease_progression 
H-positive risk:  655 694 103 1109 440 92 1043 428 156 67 168 45 
H-negative risk:  694 655 1043 1109 428 440 92 103 168 156 45 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
211 
disease_progression 
H-positive risk:  658 706 103 1106 434 93 1039 430 151 69 166 45 
H-negative risk:  706 658 1039 1106 430 434 93 103 166 151 45 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
212 
disease_progression 
H-positive risk:  661 704 103 1103 443 93 1039 423 151 67 170 43 
H-negative risk:  704 661 1039 1103 423 443 93 103 170 151 43 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
213 
disease_progression 
H-positive risk:  660 698 104 1115 431 93 1043 421 151 68 173 43 
H-negative risk:  698 660 1043 1115 421 431 93 104 173 151 43 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 93 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
214 
disease_progression 
H-positive risk:  666 689 104 1116 435 92 1040 424 153 66 171 44 
H-negative risk:  689 666 1040 1116 424 435 92 104 171 153 44 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 94 14 

clinical_engagement 
diagnosis 
demography 
94 new agents 
215 
disease_progression 
H-positive risk:  667 694 105 1111 434 90 1040 417 154 67 175 46 
H-negative risk:  694 667 1040 1111 417 434 90 105 175 154 46 67 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 90 13 

clinical_engagement 
diagnosis 
demography 
79 new agents 
216 
disease_progression 
H-positive risk:  668 697 105 1117 433 90 1044 406 155 65 176 44 
H-negative risk:  697 668 1044 1117 406 433 90 105 176 155 44 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 89 12 

clinical_engagement 
diagnosis 
demography 
90 new agents 
217 
disease_progression 
H-positive risk:  671 697 104 1113 434 87 1032 417 157 68 174 46 
H-negative risk:  697 671 1032 1113 417 434 87 104 174 157 46 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 91 12 

clinical_engagement 
diagnosis 
demography 
72 new agents 
218 
disease_progression 
H-positive risk:  667 694 103 1118 428 87 1037 420 154 71 173 48 
H-negative risk:  694 667 1037 1118 420 428 87 103 173 154 48 71 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 91 14 

clinical_engagement 
diagnosis 
demography 
89 new agents 
219 
disease_progression 
H-positive risk:  664 695 104 1120 432 87 1035 415 155 71 172 50 
H-negative risk:  695 664 1035 1120 415 432 87 104 172 155 50 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 89 15 

clinical_engagement 
diagnosis 
demography 
57 new agents 
220 
disease_progression 
H-positive risk:  669 697 103 1113 437 86 1029 416 154 71 173 52 
H-negative risk:  697 669 1029 1113 416 437 86 103 173 154 52 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 89 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
221 
disease_progression 
H-positive risk:  664 690 102 1108 439 87 1042 415 155 70 175 53 
H-negative risk:  690 664 1042 1108 415 439 87 102 175 155 53 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
222 
disease_progression 
H-positive risk:  666 696 102 1104 437 88 1045 415 152 70 170 55 
H-negative risk:  696 666 1045 1104 415 437 88 102 170 152 55 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
223 
disease_progression 
H-positive risk:  665 684 101 1115 439 87 1049 413 152 70 170 55 
H-negative risk:  684 665 1049 1115 413 439 87 101 170 152 55 70 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
224 
disease_progression 
H-positive risk:  666 676 98 1112 436 87 1067 411 153 68 171 55 
H-negative risk:  676 666 1067 1112 411 436 87 98 171 153 55 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
84 new agents 
225 
disease_progression 
H-positive risk:  666 673 99 1123 428 86 1064 412 158 66 168 57 
H-negative risk:  673 666 1064 1123 412 428 86 99 168 158 57 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
226 
disease_progression 
H-positive risk:  663 666 99 1131 430 89 1064 410 159 65 168 56 
H-negative risk:  666 663 1064 1131 410 430 89 99 168 159 56 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
227 
disease_progression 
H-positive risk:  661 667 97 1131 430 89 1076 403 163 61 167 55 
H-negative risk:  667 661 1076 1131 403 430 89 97 167 163 55 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
228 
disease_progression 
H-positive risk:  659 673 95 1126 426 91 1086 398 158 64 166 58 
H-negative risk:  673 659 1086 1126 398 426 91 95 166 158 58 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
229 
disease_progression 
H-positive risk:  664 677 91 1109 428 93 1085 408 153 66 168 58 
H-negative risk:  677 664 1085 1109 408 428 93 91 168 153 58 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
93 new agents 
230 
disease_progression 
H-positive risk:  663 682 91 1103 425 93 1080 420 152 67 169 55 
H-negative risk:  682 663 1080 1103 420 425 93 91 169 152 55 67 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
231 
disease_progression 
H-positive risk:  663 674 88 1101 438 97 1081 416 152 66 168 56 
H-negative risk:  674 663 1081 1101 416 438 97 88 168 152 56 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
88 new agents 
232 
disease_progression 
H-positive risk:  670 691 88 1092 436 93 1082 408 152 67 166 55 
H-negative risk:  691 670 1082 1092 408 436 93 88 166 152 55 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
233 
disease_progression 
H-positive risk:  676 687 89 1089 449 92 1077 401 156 65 162 57 
H-negative risk:  687 676 1077 1089 401 449 92 89 162 156 57 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
234 
disease_progression 
H-positive risk:  681 690 88 1089 447 92 1071 404 154 66 163 55 
H-negative risk:  690 681 1071 1089 404 447 92 88 163 154 55 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
235 
disease_progression 
H-positive risk:  679 691 88 1083 449 93 1080 397 154 66 161 59 
H-negative risk:  691 679 1080 1083 397 449 93 88 161 154 59 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
236 
disease_progression 
H-positive risk:  680 685 86 1088 441 94 1084 401 156 68 158 59 
H-negative risk:  685 680 1084 1088 401 441 94 86 158 156 59 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
237 
disease_progression 
H-positive risk:  674 676 86 1090 448 95 1091 398 157 68 159 58 
H-negative risk:  676 674 1091 1090 398 448 95 86 159 157 58 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
238 
disease_progression 
H-positive risk:  676 675 87 1091 447 92 1092 400 159 68 156 57 
H-negative risk:  675 676 1092 1091 400 447 92 87 156 159 57 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
239 
disease_progression 
H-positive risk:  674 671 86 1101 443 91 1098 399 158 67 158 54 
H-negative risk:  671 674 1098 1101 399 443 91 86 158 158 54 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
240 
disease_progression 
H-positive risk:  671 675 86 1099 445 88 1104 398 158 65 154 57 
H-negative risk:  675 671 1104 1099 398 445 88 86 154 158 57 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
241 
disease_progression 
H-positive risk:  673 676 86 1083 464 89 1099 397 157 66 152 58 
H-negative risk:  676 673 1099 1083 397 464 89 86 152 157 58 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
242 
disease_progression 
H-positive risk:  677 672 87 1092 457 87 1104 387 160 66 151 60 
H-negative risk:  672 677 1104 1092 387 457 87 87 151 160 60 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
243 
disease_progression 
H-positive risk:  677 667 87 1097 462 84 1105 381 162 65 152 61 
H-negative risk:  667 677 1105 1097 381 462 84 87 152 162 61 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
244 
disease_progression 
H-positive risk:  676 668 86 1097 449 87 1109 392 163 62 153 58 
H-negative risk:  668 676 1109 1097 392 449 87 86 153 163 58 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
245 
disease_progression 
H-positive risk:  673 667 88 1101 453 88 1112 387 159 64 149 59 
H-negative risk:  667 673 1112 1101 387 453 88 88 149 159 59 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
246 
disease_progression 
H-positive risk:  673 670 89 1097 451 89 1104 391 160 65 151 60 
H-negative risk:  670 673 1104 1097 391 451 89 89 151 160 60 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
247 
disease_progression 
H-positive risk:  677 673 91 1095 455 89 1094 388 158 68 150 62 
H-negative risk:  673 677 1094 1095 388 455 89 91 150 158 62 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
248 
disease_progression 
H-positive risk:  677 669 89 1104 454 86 1094 387 156 71 150 63 
H-negative risk:  669 677 1094 1104 387 454 86 89 150 156 63 71 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
249 
disease_progression 
H-positive risk:  675 667 87 1115 453 86 1092 387 158 67 147 66 
H-negative risk:  667 675 1092 1115 387 453 86 87 147 158 66 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
250 
disease_progression 
H-positive risk:  680 670 89 1110 458 85 1086 387 157 67 144 67 
H-negative risk:  670 680 1086 1110 387 458 85 89 144 157 67 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
251 
disease_progression 
H-positive risk:  682 664 93 1107 466 89 1076 390 158 68 142 65 
H-negative risk:  664 682 1076 1107 390 466 89 93 142 158 65 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
252 
disease_progression 
H-positive risk:  686 660 93 1104 476 86 1071 390 156 70 144 64 
H-negative risk:  660 686 1071 1104 390 476 86 93 144 156 64 70 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
253 
disease_progression 
H-positive risk:  692 663 95 1104 466 84 1068 392 157 72 145 62 
H-negative risk:  663 692 1068 1104 392 466 84 95 145 157 62 72 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
254 
disease_progression 
H-positive risk:  693 666 93 1108 465 84 1059 393 156 77 145 61 
H-negative risk:  666 693 1059 1108 393 465 84 93 145 156 61 77 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
255 
disease_progression 
H-positive risk:  699 666 92 1098 468 85 1062 390 157 78 144 61 
H-negative risk:  666 699 1062 1098 390 468 85 92 144 157 61 78 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
256 
disease_progression 
H-positive risk:  692 670 92 1094 476 85 1070 378 158 79 144 62 
H-negative risk:  670 692 1070 1094 378 476 85 92 144 158 62 79 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
257 
disease_progression 
H-positive risk:  689 669 90 1099 478 85 1070 377 158 79 143 63 
H-negative risk:  669 689 1070 1099 377 478 85 90 143 158 63 79 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
258 
disease_progression 
H-positive risk:  688 666 92 1106 475 83 1070 376 157 79 144 64 
H-negative risk:  666 688 1070 1106 376 475 83 92 144 157 64 79 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
259 
disease_progression 
H-positive risk:  689 664 92 1100 469 86 1076 385 155 79 143 62 
H-negative risk:  664 689 1076 1100 385 469 86 92 143 155 62 79 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
260 
disease_progression 
H-positive risk:  690 661 92 1107 464 87 1068 401 152 79 142 57 
H-negative risk:  661 690 1068 1107 401 464 87 92 142 152 57 79 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  692 670 90 1103 468 87 1063 397 153 81 142 54 
H-negative risk:  670 692 1063 1103 397 468 87 90 142 153 54 81 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
78 new agents 
262 
disease_progression 
H-positive risk:  700 674 89 1092 476 87 1061 395 153 79 144 50 
H-negative risk:  674 700 1061 1092 395 476 87 89 144 153 50 79 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
263 
disease_progression 
H-positive risk:  689 679 90 1085 480 88 1066 402 151 79 139 52 
H-negative risk:  679 689 1066 1085 402 480 88 90 139 151 52 79 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
264 
disease_progression 
H-positive risk:  687 685 89 1085 476 87 1068 400 154 79 137 53 
H-negative risk:  685 687 1068 1085 400 476 87 89 137 154 53 79 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
265 
disease_progression 
H-positive risk:  693 684 90 1095 469 88 1069 393 152 78 136 53 
H-negative risk:  684 693 1069 1095 393 469 88 90 136 152 53 78 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
100 new agents 
266 
disease_progression 
H-positive risk:  696 686 90 1095 464 89 1072 393 151 75 138 51 
H-negative risk:  686 696 1072 1095 393 464 89 90 138 151 51 75 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
267 
disease_progression 
H-positive risk:  696 687 90 1088 456 89 1081 397 148 77 139 52 
H-negative risk:  687 696 1081 1088 397 456 89 90 139 148 52 77 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
268 
disease_progression 
H-positive risk:  683 681 96 1091 460 89 1091 399 150 73 139 48 
H-negative risk:  681 683 1091 1091 399 460 89 96 139 150 48 73 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
269 
disease_progression 
H-positive risk:  681 688 98 1081 455 91 1095 397 155 73 136 50 
H-negative risk:  688 681 1095 1081 397 455 91 98 136 155 50 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
270 
disease_progression 
H-positive risk:  678 692 97 1075 459 90 1100 394 154 73 136 52 
H-negative risk:  692 678 1100 1075 394 459 90 97 136 154 52 73 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
271 
disease_progression 
H-positive risk:  680 695 97 1070 454 90 1097 398 156 76 139 48 
H-negative risk:  695 680 1097 1070 398 454 90 97 139 156 48 76 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
272 
disease_progression 
H-positive risk:  675 703 98 1073 449 89 1097 402 155 72 136 51 
H-negative risk:  703 675 1097 1073 402 449 89 98 136 155 51 72 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
273 
disease_progression 
H-positive risk:  673 701 99 1073 445 88 1102 407 152 71 137 52 
H-negative risk:  701 673 1102 1073 407 445 88 99 137 152 52 71 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
274 
disease_progression 
H-positive risk:  677 696 98 1076 448 86 1105 403 150 71 136 54 
H-negative risk:  696 677 1105 1076 403 448 86 98 136 150 54 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 71 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
275 
disease_progression 
H-positive risk:  684 696 95 1079 446 87 1103 400 148 72 139 51 
H-negative risk:  696 684 1103 1079 400 446 87 95 139 148 51 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
276 
disease_progression 
H-positive risk:  683 691 94 1091 449 88 1091 403 147 69 139 55 
H-negative risk:  691 683 1091 1091 403 449 88 94 139 147 55 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
277 
disease_progression 
H-positive risk:  687 690 96 1088 446 86 1086 409 147 70 140 55 
H-negative risk:  690 687 1086 1088 409 446 86 96 140 147 55 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
278 
disease_progression 
H-positive risk:  695 693 95 1083 447 88 1075 410 148 66 145 55 
H-negative risk:  693 695 1075 1083 410 447 88 95 145 148 55 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
83 new agents 
279 
disease_progression 
H-positive risk:  707 694 93 1083 440 86 1073 407 154 65 146 52 
H-negative risk:  694 707 1073 1083 407 440 86 93 146 154 52 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
280 
disease_progression 
H-positive risk:  705 697 89 1083 433 91 1065 416 156 65 148 52 
H-negative risk:  697 705 1065 1083 416 433 91 89 148 156 52 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
281 
disease_progression 
H-positive risk:  703 699 90 1087 433 91 1065 419 156 62 143 52 
H-negative risk:  699 703 1065 1087 419 433 91 90 143 156 52 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  697 701 91 1092 432 91 1069 418 155 59 144 51 
H-negative risk:  701 697 1069 1092 418 432 91 91 144 155 51 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
283 
disease_progression 
H-positive risk:  694 710 89 1102 427 92 1066 416 151 57 142 54 
H-negative risk:  710 694 1066 1102 416 427 92 89 142 151 54 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
284 
disease_progression 
H-positive risk:  681 703 89 1108 427 94 1084 416 149 55 143 51 
H-negative risk:  703 681 1084 1108 416 427 94 89 143 149 51 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
285 
disease_progression 
H-positive risk:  674 700 91 1112 420 93 1091 422 146 57 140 54 
H-negative risk:  700 674 1091 1112 422 420 93 91 140 146 54 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
286 
disease_progression 
H-positive risk:  678 702 94 1114 414 93 1093 417 149 56 140 50 
H-negative risk:  702 678 1093 1114 417 414 93 94 140 149 50 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
287 
disease_progression 
H-positive risk:  673 706 94 1117 417 93 1088 418 149 57 138 50 
H-negative risk:  706 673 1088 1117 418 417 93 94 138 149 50 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
288 
disease_progression 
H-positive risk:  670 701 96 1113 423 95 1090 419 147 58 139 49 
H-negative risk:  701 670 1090 1113 419 423 95 96 139 147 49 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
289 
disease_progression 
H-positive risk:  669 702 99 1111 427 94 1084 426 147 59 134 48 
H-negative risk:  702 669 1084 1111 426 427 94 99 134 147 48 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
99 new agents 
290 
disease_progression 
H-positive risk:  672 703 99 1110 423 97 1081 422 151 57 138 47 
H-negative risk:  703 672 1081 1110 422 423 97 99 138 151 47 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
291 
disease_progression 
H-positive risk:  673 701 100 1114 421 96 1078 422 155 55 135 50 
H-negative risk:  701 673 1078 1114 422 421 96 100 135 155 50 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
292 
disease_progression 
H-positive risk:  672 700 101 1111 421 93 1084 420 156 56 135 51 
H-negative risk:  700 672 1084 1111 420 421 93 101 135 156 51 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
293 
disease_progression 
H-positive risk:  678 699 96 1110 424 92 1075 418 157 58 139 54 
H-negative risk:  699 678 1075 1110 418 424 92 96 139 157 54 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
294 
disease_progression 
H-positive risk:  675 705 95 1109 425 92 1077 410 157 62 142 51 
H-negative risk:  705 675 1077 1109 410 425 92 95 142 157 51 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
295 
disease_progression 
H-positive risk:  684 698 91 1099 428 93 1084 410 160 59 145 49 
H-negative risk:  698 684 1084 1099 410 428 93 91 145 160 49 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
296 
disease_progression 
H-positive risk:  689 694 92 1108 427 90 1086 402 161 61 140 50 
H-negative risk:  694 689 1086 1108 402 427 90 92 140 161 50 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
297 
disease_progression 
H-positive risk:  687 685 94 1115 429 88 1084 400 164 62 141 51 
H-negative risk:  685 687 1084 1115 400 429 88 94 141 164 51 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
298 
disease_progression 
H-positive risk:  691 690 95 1117 427 88 1079 400 164 58 141 50 
H-negative risk:  690 691 1079 1117 400 427 88 95 141 164 50 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
299 
disease_progression 
H-positive risk:  700 694 93 1116 426 88 1070 400 164 61 139 49 
H-negative risk:  694 700 1070 1116 400 426 88 93 139 164 49 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
300 
disease_progression 
H-positive risk:  685 688 92 1125 423 87 1091 396 160 64 139 50 
H-negative risk:  688 685 1091 1125 396 423 87 92 139 160 50 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
301 
disease_progression 
H-positive risk:  680 689 91 1132 410 87 1105 396 158 64 138 50 
H-negative risk:  689 680 1105 1132 396 410 87 91 138 158 50 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
302 
disease_progression 
H-positive risk:  685 692 92 1135 394 87 1106 403 157 61 139 49 
H-negative risk:  692 685 1106 1135 403 394 87 92 139 157 49 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
303 
disease_progression 
H-positive risk:  688 699 95 1134 392 85 1098 401 160 60 138 50 
H-negative risk:  699 688 1098 1134 401 392 85 95 138 160 50 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
304 
disease_progression 
H-positive risk:  685 692 95 1139 392 87 1090 411 158 60 141 50 
H-negative risk:  692 685 1090 1139 411 392 87 95 141 158 50 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
305 
disease_progression 
H-positive risk:  691 687 97 1125 387 88 1101 415 154 58 143 54 
H-negative risk:  687 691 1101 1125 415 387 88 97 143 154 54 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
306 
disease_progression 
H-positive risk:  700 680 96 1132 396 90 1092 410 149 62 142 51 
H-negative risk:  680 700 1092 1132 410 396 90 96 142 149 51 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
307 
disease_progression 
H-positive risk:  697 677 97 1135 400 90 1087 411 153 59 143 51 
H-negative risk:  677 697 1087 1135 411 400 90 97 143 153 51 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
308 
disease_progression 
H-positive risk:  688 681 99 1140 391 91 1095 409 152 59 142 53 
H-negative risk:  681 688 1095 1140 409 391 91 99 142 152 53 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
309 
disease_progression 
H-positive risk:  684 679 99 1138 391 91 1102 411 150 59 144 52 
H-negative risk:  679 684 1102 1138 411 391 91 99 144 150 52 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
310 
disease_progression 
H-positive risk:  683 680 97 1137 383 92 1109 415 150 58 144 52 
H-negative risk:  680 683 1109 1137 415 383 92 97 144 150 52 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
311 
disease_progression 
H-positive risk:  683 687 95 1129 387 98 1100 415 145 60 149 52 
H-negative risk:  687 683 1100 1129 415 387 98 95 149 145 52 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
312 
disease_progression 
H-positive risk:  686 683 93 1141 378 97 1111 410 144 57 148 52 
H-negative risk:  683 686 1111 1141 410 378 97 93 148 144 52 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
313 
disease_progression 
H-positive risk:  690 684 92 1133 384 99 1106 417 138 57 146 54 
H-negative risk:  684 690 1106 1133 417 384 99 92 146 138 54 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
314 
disease_progression 
H-positive risk:  693 681 90 1136 386 100 1101 419 136 55 147 56 
H-negative risk:  681 693 1101 1136 419 386 100 90 147 136 56 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
315 
disease_progression 
H-positive risk:  686 681 89 1117 405 103 1108 413 137 54 151 56 
H-negative risk:  681 686 1108 1117 413 405 103 89 151 137 56 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
316 
disease_progression 
H-positive risk:  691 682 90 1122 405 105 1101 411 134 50 153 56 
H-negative risk:  682 691 1101 1122 411 405 105 90 153 134 56 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
92 new agents 
317 
disease_progression 
H-positive risk:  693 689 93 1119 396 106 1099 412 132 52 152 57 
H-negative risk:  689 693 1099 1119 412 396 106 93 152 132 57 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
318 
disease_progression 
H-positive risk:  701 689 94 1114 397 101 1087 417 137 52 154 57 
H-negative risk:  689 701 1087 1114 417 397 101 94 154 137 57 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
319 
disease_progression 
H-positive risk:  705 684 94 1120 395 101 1088 413 140 49 155 56 
H-negative risk:  684 705 1088 1120 413 395 101 94 155 140 56 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
320 
disease_progression 
H-positive risk:  707 685 94 1111 394 100 1099 402 140 50 161 57 
H-negative risk:  685 707 1099 1111 402 394 100 94 161 140 57 50 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
104 new agents 
321 
disease_progression 
H-positive risk:  708 689 95 1103 395 104 1097 403 141 47 164 54 
H-negative risk:  689 708 1097 1103 403 395 104 95 164 141 54 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
322 
disease_progression 
H-positive risk:  703 688 96 1104 386 105 1109 405 141 47 163 53 
H-negative risk:  688 703 1109 1104 405 386 105 96 163 141 53 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
323 
disease_progression 
H-positive risk:  703 686 95 1104 390 106 1115 400 139 49 157 56 
H-negative risk:  686 703 1115 1104 400 390 106 95 157 139 56 49 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
324 
disease_progression 
H-positive risk:  698 690 95 1103 391 108 1111 409 139 45 155 56 
H-negative risk:  690 698 1111 1103 409 391 108 95 155 139 56 45 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
325 
disease_progression 
H-positive risk:  699 690 94 1099 393 107 1110 410 135 48 162 53 
H-negative risk:  690 699 1110 1099 410 393 107 94 162 135 53 48 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
326 
disease_progression 
H-positive risk:  693 697 92 1087 390 105 1118 418 140 47 165 48 
H-negative risk:  697 693 1118 1087 418 390 105 92 165 140 48 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
327 
disease_progression 
H-positive risk:  689 694 91 1089 386 106 1118 430 138 46 161 52 
H-negative risk:  694 689 1118 1089 430 386 106 91 161 138 52 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
328 
disease_progression 
H-positive risk:  692 702 91 1082 386 107 1110 428 140 48 161 53 
H-negative risk:  702 692 1110 1082 428 386 107 91 161 140 53 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
329 
disease_progression 
H-positive risk:  687 701 88 1088 381 106 1107 436 143 48 159 56 
H-negative risk:  701 687 1107 1088 436 381 106 88 159 143 56 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
330 
disease_progression 
H-positive risk:  686 701 85 1082 387 108 1100 443 139 50 161 58 
H-negative risk:  701 686 1100 1082 443 387 108 85 161 139 58 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
331 
disease_progression 
H-positive risk:  696 698 86 1077 386 107 1099 438 139 55 161 58 
H-negative risk:  698 696 1099 1077 438 386 107 86 161 139 58 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
332 
disease_progression 
H-positive risk:  696 695 86 1073 390 106 1092 445 140 56 162 59 
H-negative risk:  695 696 1092 1073 445 390 106 86 162 140 59 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
333 
disease_progression 
H-positive risk:  690 694 87 1066 394 106 1093 447 144 59 161 59 
H-negative risk:  694 690 1093 1066 447 394 106 87 161 144 59 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
334 
disease_progression 
H-positive risk:  691 698 84 1060 393 105 1095 448 145 60 161 60 
H-negative risk:  698 691 1095 1060 448 393 105 84 161 145 60 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
335 
disease_progression 
H-positive risk:  686 691 86 1072 392 106 1106 440 145 60 157 59 
H-negative risk:  691 686 1106 1072 440 392 106 86 157 145 59 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
108 new agents 
336 
disease_progression 
H-positive risk:  692 693 81 1075 390 105 1113 430 144 59 156 62 
H-negative risk:  693 692 1113 1075 430 390 105 81 156 144 62 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
337 
disease_progression 
H-positive risk:  693 687 82 1074 384 104 1116 436 145 60 156 63 
H-negative risk:  687 693 1116 1074 436 384 104 82 156 145 63 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
338 
disease_progression 
H-positive risk:  688 684 84 1089 377 103 1123 433 144 59 157 59 
H-negative risk:  684 688 1123 1089 433 377 103 84 157 144 59 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
339 
disease_progression 
H-positive risk:  698 678 87 1095 377 102 1119 427 146 58 156 57 
H-negative risk:  678 698 1119 1095 427 377 102 87 156 146 57 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
340 
disease_progression 
H-positive risk:  696 680 84 1096 383 101 1125 422 142 57 155 59 
H-negative risk:  680 696 1125 1096 422 383 101 84 155 142 59 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
341 
disease_progression 
H-positive risk:  694 671 88 1098 382 100 1132 419 143 60 154 59 
H-negative risk:  671 694 1132 1098 419 382 100 88 154 143 59 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
86 new agents 
342 
disease_progression 
H-positive risk:  698 684 88 1081 382 101 1144 409 143 57 153 60 
H-negative risk:  684 698 1144 1081 409 382 101 88 153 143 60 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
343 
disease_progression 
H-positive risk:  694 691 86 1080 382 99 1150 402 144 54 157 61 
H-negative risk:  691 694 1150 1080 402 382 99 86 157 144 61 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
344 
disease_progression 
H-positive risk:  696 693 84 1086 379 101 1134 407 143 56 160 61 
H-negative risk:  693 696 1134 1086 407 379 101 84 160 143 61 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
345 
disease_progression 
H-positive risk:  695 687 84 1088 381 103 1137 408 145 54 157 61 
H-negative risk:  687 695 1137 1088 408 381 103 84 157 145 61 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
346 
disease_progression 
H-positive risk:  691 685 85 1088 392 103 1131 409 143 54 158 61 
H-negative risk:  685 691 1131 1088 409 392 103 85 158 143 61 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
61 new agents 
347 
disease_progression 
H-positive risk:  685 688 85 1080 394 103 1134 415 144 56 153 63 
H-negative risk:  688 685 1134 1080 415 394 103 85 153 144 63 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
348 
disease_progression 
H-positive risk:  688 691 85 1076 394 103 1133 416 143 57 151 63 
H-negative risk:  691 688 1133 1076 416 394 103 85 151 143 63 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
349 
disease_progression 
H-positive risk:  688 688 87 1081 389 101 1132 419 147 56 153 59 
H-negative risk:  688 688 1132 1081 419 389 101 87 153 147 59 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
350 
disease_progression 
H-positive risk:  688 693 87 1081 388 100 1135 414 149 55 155 55 
H-negative risk:  693 688 1135 1081 414 388 100 87 155 149 55 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
351 
disease_progression 
H-positive risk:  684 699 86 1071 396 98 1138 413 149 56 155 55 
H-negative risk:  699 684 1138 1071 413 396 98 86 155 149 55 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
61 new agents 
352 
disease_progression 
H-positive risk:  680 694 84 1077 398 99 1134 416 151 56 156 55 
H-negative risk:  694 680 1134 1077 416 398 99 84 156 151 55 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
353 
disease_progression 
H-positive risk:  675 689 82 1085 402 100 1137 416 147 56 156 55 
H-negative risk:  689 675 1137 1085 416 402 100 82 156 147 55 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
354 
disease_progression 
H-positive risk:  677 684 79 1091 407 102 1119 428 145 57 156 55 
H-negative risk:  684 677 1119 1091 428 407 102 79 156 145 55 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
355 
disease_progression 
H-positive risk:  673 685 80 1092 401 102 1127 430 147 55 152 56 
H-negative risk:  685 673 1127 1092 430 401 102 80 152 147 56 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
356 
disease_progression 
H-positive risk:  676 682 79 1088 405 103 1119 436 152 54 151 55 
H-negative risk:  682 676 1119 1088 436 405 103 79 151 152 55 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
357 
disease_progression 
H-positive risk:  676 685 80 1086 411 103 1103 444 151 55 151 55 
H-negative risk:  685 676 1103 1086 444 411 103 80 151 151 55 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
86 new agents 
358 
disease_progression 
H-positive risk:  682 690 81 1086 403 106 1101 444 148 54 147 58 
H-negative risk:  690 682 1101 1086 444 403 106 81 147 148 58 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
62 new agents 
359 
disease_progression 
H-positive risk:  685 688 79 1088 409 104 1095 445 149 52 150 56 
H-negative risk:  688 685 1095 1088 445 409 104 79 150 149 56 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
85 new agents 
360 
disease_progression 
H-positive risk:  688 693 75 1080 422 106 1090 441 146 54 149 56 
H-negative risk:  693 688 1090 1080 441 422 106 75 149 146 56 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
Time difference of 17.71333 mins
This is task 3
date
